Fitbit announced this week regulatory clearance in both the US and Europe for its electrocardiogram (ECG) app to identify atrial fibrillation (AFib). The company received an 510(k) designation for its app to assess AFib, a condition that affects more than 33.5 million people globally. According to the company, the new ECG app allows people to take on-the-spot readings to check for AFib at any time. It adds to the expanding suite of applications Fitbit has been racing to incorporate into its wearable devices such as blood oxygen measurement and early detection of COVID-19.
Why it matters
The news builds momentum for Fitbit which has been propelled center stage of big tech competition. Last year Google announced its intention to